Back to search

Article

Cancer-derived mutation in the OGA stalk domain promotes cell malignancy through dysregulating PDLIM7 and p53

2023-03-20

Abstract excerpt

<title>Abstract</title> <p>O-GlcNAcase (OGA) is the sole enzyme that hydrolyzes O-GlcNAcylation from thousands of proteins and is dysregulated in many diseases including cancer. However, the substrate recognition and pathogenic mechanisms of OGA remain largely unknown. Here we report the first discovery of a cancer-derived point mutation on the OGA’s non-catalytic stalk domain that aberrantly regulated a small se...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ff5e59e2-0de3-51f1-ba23-4fe0b2758fc5
DOI
10.21203/rs.3.rs-2709128/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cancer-derived mutation in the OGA stalk domain promotes cell malignancy through dysregulating PDLIM7 and p53DOI 10.21203/rs.3.rs-2709128/v1
Select a neighboring publication to make it the new centre.